Tags

Type your tag names separated by a space and hit enter

[An update on scalp psoriasis].
Actas Dermosifiliogr. 2009 Sep; 100(7):536-43.AD

Abstract

Between 50 % and 80 % of patients with psoriasis have involvement of the scalp. The clinical presentation of scalp psoriasis can be very varied, with disease severity ranging from mild to extremely severe.The disease may have a major psychological impact. Treatment should be tailored to each individual in order to achieve a good clinical response or blanching that lasts for as long as possible, with a safe and convenient regimen. Many different treatments have been tried: phototherapy, pulsed magnetic fields, Grenz rays, keratolytics, coal tar, antifungals, dithranol, retinoids, vitamin D analogues, corticosteroids, and systemic treatment. Ideally, for scalp psoriasis, treatment should be effective; applied in the form of a lotion, foam, or emulsion; require few applications per week; and have proven long-term safety. One such treatment is potent corticosteroids and vitamin D3 analogues in combination, which has a fast onset of action and proven long-term safety.

Links

FREE Publisher Full Text

Authors+Show Affiliations

Sola-Ortigosa J
Unidad de Psoriasis y Fototerapia, Unidad Docente de la Universidad de Barcelona. Barcelona. España. 38725jso@comb.es
Sánchez-Regaña M
No affiliation info available
Umbert-Millet P
No affiliation info available

MeSH

Diagnosis, DifferentialHumansPsoriasisScalp Dermatoses

Pub Type(s)

English Abstract
Journal Article
Review

Language

spa

PubMed ID

19715638

Citation

Sola-Ortigosa, J, et al. "[An Update On Scalp Psoriasis]." Actas Dermo-sifiliograficas, vol. 100, no. 7, 2009, pp. 536-43.
Sola-Ortigosa J, Sánchez-Regaña M, Umbert-Millet P. [An update on scalp psoriasis]. Actas Dermosifiliogr. 2009;100(7):536-43.
Sola-Ortigosa, J., Sánchez-Regaña, M., & Umbert-Millet, P. (2009). [An update on scalp psoriasis]. Actas Dermo-sifiliograficas, 100(7), 536-43.
Sola-Ortigosa J, Sánchez-Regaña M, Umbert-Millet P. [An Update On Scalp Psoriasis]. Actas Dermosifiliogr. 2009;100(7):536-43. PubMed PMID: 19715638.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [An update on scalp psoriasis]. AU - Sola-Ortigosa,J, AU - Sánchez-Regaña,M, AU - Umbert-Millet,P, PY - 2009/9/1/entrez PY - 2009/9/1/pubmed PY - 2010/1/7/medline SP - 536 EP - 43 JF - Actas dermo-sifiliograficas JO - Actas Dermosifiliogr VL - 100 IS - 7 N2 - Between 50 % and 80 % of patients with psoriasis have involvement of the scalp. The clinical presentation of scalp psoriasis can be very varied, with disease severity ranging from mild to extremely severe.The disease may have a major psychological impact. Treatment should be tailored to each individual in order to achieve a good clinical response or blanching that lasts for as long as possible, with a safe and convenient regimen. Many different treatments have been tried: phototherapy, pulsed magnetic fields, Grenz rays, keratolytics, coal tar, antifungals, dithranol, retinoids, vitamin D analogues, corticosteroids, and systemic treatment. Ideally, for scalp psoriasis, treatment should be effective; applied in the form of a lotion, foam, or emulsion; require few applications per week; and have proven long-term safety. One such treatment is potent corticosteroids and vitamin D3 analogues in combination, which has a fast onset of action and proven long-term safety. SN - 0001-7310 UR - https://www.unboundmedicine.com/medline/citation/19715638/[An_update_on_scalp_psoriasis]_ L2 - https://www.elsevier.es/en/linksolver/pdf/pii/S0001-7310(09)71901-5 DB - PRIME DP - Unbound Medicine ER -